Association between Epstein-Barr Virus Gene Polymorphism and Breast Cancer Risk among Egyptian Females

Document Type : Research Articles

Authors

1 Department of Clinical Pathology, Clinical Microbiology Unit, Faculty of Medicine, Mansoura University, Egypt.

2 Department of Pathology, Faculty of Medicine, Mansoura University, Egypt.

3 Surgical Oncology, Oncology Center Mansoura University, Faculty of Medicine, Mansoura University, Egypt.

4 Clinical Pathology Department, Clinical Chemistry Unit, Faculty of Medicine, Mansoura University, Egypt.

Abstract

Background: Epstein-Barr virus (EBV) has been implicated in the development of breast cancer (BC) since 1995. It is classified into A/B genotypes, C/D subtypes, and F/f variants according to variations in its genome. Aim: To determine the distribution difference of EBV types between BC patients and healthy controls in Egypt and to detect the association between different EBV types and BC characteristics. Methods: Three hundred and sixty-two participants (142 BC patients and 220 controls) were enrolled in this study. All participants were screened for EBV infection by determination of viral-capsid-IgG antibodies in their sera. EBNA-1 gene was detected by PCR in tumor biopsies of seropositive patients and in peripheral blood mononuclear cells of controls. A/B genotyping of EBV was performed by nested-PCR targeting the EBNA-2 gene. C/D subtypes and F/f variants were identified by Restriction fragment length polymorphism at BamHI-I W1/I1 and BamHI-F regions of EBV genome, respectively. Results: Among 362 participants, 300(82.9%) were EBV-seropositive, including 120/142(84.5%) of the BC patients and 180/220(81.8 %) of the controls. EBNA-1 gene was positive in 54(45%) of seropositive BC patients and in 38(21.1%) of seropositive controls. There was a significant association of EBNA-1 gene with breast cancer (OR=3.05, 95%CI=1.84-5.07). Moreover, EBNA-1 gene positivity was significantly associated with the more aggressive tumors. Genotype-A and prototype-F were predominant among patients (90.4%, 100%, respectively) as well as among controls (91.7%, 100%, respectively) with no statistical significant association with BC risk.  However, subtype-D was significantly more frequent in patients (95.6%) than in controls (64.7%) and was significantly associated with a higher BC risk as compared to subtype-C (OR=11.7, 95%CI=2.4-57.08). Subtype-D was significantly associated with higher grades tumors (100% among grade III),  with progesteron receptor-negative tumors and with HER2-positive tumors (100% for each). The combined genotypes that significantly associated with BC risk were ADF (OR=4.9) and BDF (OR=5.5). Conclusions: Subtype-D of EBV could be the only EBV type implicated in BC development among Egyptian females and associated more with poor prognosis.

Keywords

Main Subjects

Asian Pacific Journal of Cancer Prevention
Volume 23, Issue 2
February 2022
Pages 641-650

Files

History

  • Receive Date: 24 November 2021
  • Revise Date: 31 December 2021
  • Accept Date: 15 February 2022

Share

How to cite

Statistics